Nifty

:

25149.85

Sensex

:

82500.47

-205.40 (-0.81%)
-689.81 (-0.83%)

Login

Nifty
Sensex

:
:

25149.85
82500.47

-205.40 (-0.81%)
-689.81 (-0.83%)

IOL Chemicals And Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - API

Rating :

N/A

BSE: 524164 | NSE: IOLCP

Watchlist

NSE BSE

91.18

11-Jul-2025

Open
High
Low
Previous Close

91.05
94.39
90.85
91.05

Volume
Traded Value (lacs)
52 Week High
52 Week Low

1227006
113197125.12
107.54
57.5

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,677.85
26.50
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

2,586.95
N/A
1.59

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

18.68
2.40
-0.79

EBITDA CAGR (%)

10 Years
5 Years
3 Years

35.29
-16.60
-2.24

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-17.82
-7.10

P:E (Median)

8 Years
5 Years
3 Years

17.33
17.33
17.33

P:BV (Average)

8 Years
5 Years
3 Years

1.47
1.47
1.47

EV:EBITDA (Average)

8 Years
5 Years
3 Years

8.94
8.94
8.94

Earnings Forecasts:

(Updated: 06-06-2025)

Description 2024 2025 2026 2027
Adj EPS 4.58 3.44 4.6 5.7
P/E Ratio 3.81 5.08 3.80 3.06
Revenue 2133 2079 2314 2589
EBITDA 231 202 248 293
Net Income 134 101 134 167
ROA 6.3 4.4 8.2 10
P/B Ratio 0.32 0.30 0.30 0.29
ROE 8.62 6.13 7.8 9.5
FCFF 13 -37 91 115
FCFF Yield 0.53 -1.5 3.67 4.61
Net Debt -113 -94 7 10
BVPS 54.9 57.49 58.09 60.89

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 527.78 503.92 4.73% 523.30 520.39 0.56% 525.75 545.30 -3.59% 502.38 563.18 -10.80%
Expenses 464.84 453.84 2.42% 476.43 475.91 0.11% 484.19 481.20 0.62% 451.58 490.32 -7.90%
EBITDA 62.94 50.08 25.68% 46.87 44.48 5.37% 41.56 64.10 -35.16% 50.80 72.86 -30.28%
EBIDTM 11.93% 9.94% 8.96% 8.55% 7.90% 11.76% 10.11% 12.94%
Other Income 4.52 7.52 -39.89% 4.07 8.38 -51.43% 6.43 7.11 -9.56% 7.38 7.06 4.53%
Interest 4.03 3.41 18.18% 4.46 4.30 3.72% 4.12 4.44 -7.21% 2.15 3.95 -45.57%
Depreciation 18.53 16.42 12.85% 18.66 16.32 14.34% 17.93 15.67 14.42% 16.80 14.44 16.34%
PBT 44.90 37.77 18.88% 27.82 32.24 -13.71% 25.94 51.10 -49.24% 39.23 61.53 -36.24%
Tax 13.28 9.58 38.62% 7.27 9.01 -19.31% 6.79 13.31 -48.99% 9.55 15.32 -37.66%
PAT 31.62 28.19 12.17% 20.55 23.23 -11.54% 19.15 37.79 -49.33% 29.68 46.21 -35.77%
PATM 5.99% 5.59% 3.93% 4.46% 3.64% 6.93% 5.91% 8.21%
EPS 1.08 0.96 12.50% 0.70 0.79 -11.39% 0.65 1.29 -49.61% 1.01 1.57 -35.67%

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 527.78 503.92 4.73% 523.30 520.39 0.56% 525.75 545.30 -3.59% 502.38 563.18 -10.80%
Expenses 465.03 454.40 2.34% 476.43 476.04 0.08% 484.18 481.10 0.64% 451.27 490.66 -8.03%
EBITDA 62.75 49.52 26.72% 46.87 44.35 5.68% 41.57 64.20 -35.25% 51.11 72.52 -29.52%
EBIDTM 11.89% 9.83% 8.96% 8.52% 7.91% 11.77% 10.17% 12.88%
Other Income 4.53 7.52 -39.76% 4.07 8.38 -51.43% 6.43 7.11 -9.56% 7.38 7.06 4.53%
Interest 4.03 3.41 18.18% 4.46 4.30 3.72% 4.12 4.44 -7.21% 2.15 3.95 -45.57%
Depreciation 18.55 16.43 12.90% 18.68 16.34 14.32% 17.94 15.69 14.34% 16.82 14.45 16.40%
PBT 44.70 37.20 20.16% 27.80 32.09 -13.37% 25.94 51.18 -49.32% 39.52 61.18 -35.40%
Tax 13.28 9.58 38.62% 7.27 9.01 -19.31% 6.79 13.31 -48.99% 9.55 15.32 -37.66%
PAT 31.42 27.62 13.76% 20.53 23.08 -11.05% 19.15 37.87 -49.43% 29.97 45.86 -34.65%
PATM 5.95% 5.48% 3.92% 4.44% 3.64% 6.94% 5.97% 8.14%
EPS 1.07 0.94 13.83% 0.70 0.79 -11.39% 0.65 1.29 -49.61% 1.02 1.56 -34.62%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 2,079.21 2,132.79 2,217.11 2,184.02 1,966.98 1,894.47 1,685.33 983.30 710.65 580.42 384.73 Net Sales Growth -2.51% -3.80% 1.52% 11.03% 3.83% 12.41% 71.40% 38.37% 22.44% 50.86% Cost Of Goods Sold 1,391.85 1,396.95 1,547.09 1,570.51 1,102.84 1,065.01 1,047.25 695.28 477.40 416.20 279.34 Gross Profit 687.36 735.84 670.02 613.51 864.14 829.46 638.08 288.02 233.25 164.21 105.38 GP Margin 33.06% 34.50% 30.22% 28.09% 43.93% 43.78% 37.86% 29.29% 32.82% 28.29% 27.39% Total Expenditure 1,877.04 1,901.27 1,990.59 1,927.74 1,375.14 1,320.59 1,275.68 863.77 608.45 529.04 373.46 Power & Fuel Cost - 149.05 131.98 78.18 51.46 65.12 63.94 45.66 37.45 46.57 48.58 % Of Sales - 6.99% 5.95% 3.58% 2.62% 3.44% 3.79% 4.64% 5.27% 8.02% 12.63% Employee Cost - 201.02 168.21 141.30 115.55 97.20 78.43 56.10 43.18 35.13 24.72 % Of Sales - 9.43% 7.59% 6.47% 5.87% 5.13% 4.65% 5.71% 6.08% 6.05% 6.43% Manufacturing Exp. - 47.67 43.07 36.86 28.13 28.37 25.68 22.57 16.77 8.83 4.55 % Of Sales - 2.24% 1.94% 1.69% 1.43% 1.50% 1.52% 2.30% 2.36% 1.52% 1.18% General & Admin Exp. - 9.00 6.52 5.12 4.48 2.86 2.63 1.39 1.19 1.17 1.40 % Of Sales - 0.42% 0.29% 0.23% 0.23% 0.15% 0.16% 0.14% 0.17% 0.20% 0.36% Selling & Distn. Exp. - 51.25 61.85 66.84 50.78 48.45 46.72 33.73 20.81 12.81 6.39 % Of Sales - 2.40% 2.79% 3.06% 2.58% 2.56% 2.77% 3.43% 2.93% 2.21% 1.66% Miscellaneous Exp. - 46.33 31.87 28.93 21.90 13.58 11.03 9.04 11.65 8.33 6.39 % Of Sales - 2.17% 1.44% 1.32% 1.11% 0.72% 0.65% 0.92% 1.64% 1.44% 2.20% EBITDA 202.17 231.52 226.52 256.28 591.84 573.88 409.65 119.53 102.20 51.38 11.27 EBITDA Margin 9.72% 10.86% 10.22% 11.73% 30.09% 30.29% 24.31% 12.16% 14.38% 8.85% 2.93% Other Income 22.40 30.07 25.57 32.04 24.30 16.02 10.37 6.33 1.25 1.23 1.32 Interest 14.76 16.10 16.47 8.29 5.83 20.93 51.42 64.35 67.68 61.47 59.11 Depreciation 71.92 62.85 46.13 43.26 38.92 35.73 32.45 30.21 29.84 29.69 28.91 PBT 137.89 182.64 189.49 236.77 571.39 533.24 336.15 31.30 5.93 -38.55 -75.44 Tax 36.89 47.22 49.51 57.18 126.83 171.95 99.45 3.60 1.26 1.48 -8.79 Tax Rate 26.75% 25.85% 26.13% 25.66% 22.20% 32.25% 29.59% 11.50% 21.25% -3.84% 11.65% PAT 101.00 135.42 139.98 165.66 444.56 361.29 236.70 27.70 4.67 -40.03 -66.65 PAT before Minority Interest 101.00 135.42 139.98 165.66 444.56 361.29 236.70 27.70 4.67 -40.03 -66.65 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 4.86% 6.35% 6.31% 7.59% 22.60% 19.07% 14.04% 2.82% 0.66% -6.90% -17.32% PAT Growth -25.42% -3.26% -15.50% -62.74% 23.05% 52.64% 754.51% 493.15% - - EPS 3.44 4.61 4.77 5.64 15.15 12.31 8.06 0.94 0.16 -1.36 -2.27

Description TTM Mar 24 Mar 23 Mar 22
Net Sales 2,079.21 2,132.79 2,217.11 2,184.02 Net Sales Growth -2.51% -3.80% 1.52% Cost Of Goods Sold 1,391.85 1,396.95 1,547.09 1,570.51 Gross Profit 687.36 735.84 670.02 613.51 GP Margin 33.06% 34.50% 30.22% 28.09% Total Expenditure 1,876.91 1,902.20 1,991.44 1,925.73 Power & Fuel Cost - 149.05 131.98 78.18 % Of Sales - 6.99% 5.95% 3.58% Employee Cost - 201.02 168.21 141.30 % Of Sales - 9.43% 7.59% 6.47% Manufacturing Exp. - 47.67 43.07 36.86 % Of Sales - 2.24% 1.94% 1.69% General & Admin Exp. - 9.01 6.54 5.12 % Of Sales - 0.42% 0.29% 0.23% Selling & Distn. Exp. - 51.25 61.85 66.84 % Of Sales - 2.40% 2.79% 3.06% Miscellaneous Exp. - 47.25 32.70 26.92 % Of Sales - 2.22% 1.47% 1.23% EBITDA 202.30 230.59 225.67 258.29 EBITDA Margin 9.73% 10.81% 10.18% 11.83% Other Income 22.41 30.07 25.61 32.04 Interest 14.76 16.10 16.47 8.29 Depreciation 71.99 62.91 46.16 43.26 PBT 137.96 181.65 188.65 238.78 Tax 36.89 47.22 49.51 57.18 Tax Rate 26.74% 26.00% 26.24% 25.43% PAT 101.07 134.43 139.14 167.67 PAT before Minority Interest 101.07 134.43 139.14 167.67 Minority Interest 0.00 0.00 0.00 0.00 PAT Margin 4.86% 6.30% 6.28% 7.68% PAT Growth -24.82% -3.39% -17.02% EPS 3.44 4.58 4.74 5.71

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 1,611.33 1,506.55 1,390.27 1,260.43 813.54 474.34 215.74 188.70 185.13 207.20 Share Capital 58.71 58.71 58.71 58.71 56.89 56.89 56.21 56.21 56.21 47.66 Total Reserves 1,552.62 1,447.84 1,331.56 1,201.72 747.33 408.13 159.53 132.49 128.92 153.56 Non-Current Liabilities 72.89 58.15 56.62 59.11 79.73 210.65 280.29 294.23 304.43 285.87 Secured Loans 0.00 0.00 0.00 0.00 0.00 189.88 236.16 262.37 283.25 253.84 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 21.96 22.61 18.62 23.26 Long Term Provisions 6.71 1.65 3.01 3.68 3.85 4.59 2.04 1.50 1.18 0.30 Current Liabilities 596.85 502.17 575.29 432.80 453.63 324.79 350.97 327.67 282.92 208.54 Trade Payables 469.18 314.22 409.29 238.83 180.38 120.27 157.61 149.84 115.68 70.25 Other Current Liabilities 54.42 53.93 54.02 41.00 34.46 63.88 50.97 35.84 30.03 17.81 Short Term Borrowings 32.76 79.63 42.75 0.00 55.92 67.72 135.27 140.77 137.09 120.44 Short Term Provisions 40.49 54.39 69.23 152.97 182.87 72.92 7.12 1.22 0.13 0.04 Total Liabilities 2,281.07 2,066.87 2,022.18 1,752.34 1,346.90 1,009.78 847.00 810.60 772.48 701.61 Net Block 932.69 751.31 560.64 512.36 469.04 411.72 405.64 373.88 399.50 402.82 Gross Block 1,236.41 994.71 761.99 677.69 595.78 503.91 465.53 403.77 619.96 594.29 Accumulated Depreciation 303.72 243.40 201.35 165.33 126.74 92.19 59.89 29.89 220.47 191.47 Non Current Assets 1,124.49 1,101.54 881.58 600.19 498.99 457.60 416.02 395.94 415.63 418.12 Capital Work in Progress 100.87 89.64 105.20 48.27 19.19 27.02 6.95 21.26 4.31 4.21 Non Current Investment 17.71 17.71 0.10 0.00 0.00 0.00 0.00 0.05 0.04 0.04 Long Term Loans & Adv. 23.62 9.52 10.77 17.61 1.33 11.56 1.26 0.38 9.01 10.75 Other Non Current Assets 49.60 233.36 204.87 21.95 9.43 7.30 2.17 0.37 2.77 0.30 Current Assets 1,156.58 965.33 1,140.60 1,152.15 847.91 552.18 430.98 414.66 356.86 283.49 Current Investments 2.88 2.56 2.37 1.22 0.05 0.06 0.06 0.05 0.05 0.01 Inventories 424.84 325.52 409.89 295.15 187.52 188.86 207.45 262.63 227.94 213.42 Sundry Debtors 471.23 505.28 469.80 300.31 272.42 199.16 146.14 112.77 87.26 32.67 Cash & Bank 142.62 20.90 137.88 364.74 154.65 29.60 17.32 16.81 11.94 12.70 Other Current Assets 115.01 22.18 30.99 38.52 233.27 134.50 60.01 22.40 29.67 24.68 Short Term Loans & Adv. 90.10 88.89 89.67 152.21 208.87 126.88 56.79 18.79 26.78 22.19 Net Current Assets 559.73 463.16 565.31 719.35 394.28 227.39 80.01 86.99 73.93 74.95 Total Assets 2,281.07 2,066.87 2,022.18 1,752.34 1,346.90 1,009.78 847.00 810.60 772.49 701.61

Description Mar 24 Mar 23 Mar 22
Shareholder's Funds 1,611.51 1,507.72 1,392.28 Share Capital 58.71 58.71 58.71 Total Reserves 1,552.80 1,449.01 1,333.57 Non-Current Liabilities 72.89 58.15 56.62 Secured Loans 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 Long Term Provisions 6.71 1.65 3.01 Current Liabilities 597.10 502.52 575.29 Trade Payables 469.18 314.22 409.29 Other Current Liabilities 54.67 54.28 54.02 Short Term Borrowings 32.76 79.63 42.75 Short Term Provisions 40.49 54.39 69.23 Total Liabilities 2,281.50 2,068.39 2,024.19 Net Block 933.13 751.81 560.64 Gross Block 1,236.94 995.24 761.99 Accumulated Depreciation 303.81 243.43 201.35 Non Current Assets 1,124.63 1,101.74 881.48 Capital Work in Progress 100.87 89.64 105.20 Non Current Investment 17.41 17.41 0.00 Long Term Loans & Adv. 23.62 9.52 10.77 Other Non Current Assets 49.60 233.36 204.87 Current Assets 1,156.87 966.65 1,142.71 Current Investments 2.88 2.56 2.37 Inventories 424.84 325.52 409.89 Sundry Debtors 471.23 505.28 469.80 Cash & Bank 142.89 21.83 139.99 Other Current Assets 115.03 29.86 30.99 Short Term Loans & Adv. 90.12 81.60 89.67 Net Current Assets 559.77 464.13 567.42 Total Assets 2,281.50 2,068.39 2,024.19

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 290.76 123.14 91.04 379.78 470.80 273.17 119.72 83.34 17.70 -46.96 PBT 182.64 189.49 222.84 571.39 533.24 336.15 31.30 5.93 -38.55 -75.44 Adjustment 60.06 44.42 33.12 27.15 51.93 82.35 91.64 95.92 83.92 81.73 Changes in Working Capital 90.08 -63.67 -102.34 -76.51 2.78 -77.64 3.14 -17.45 -27.67 -52.83 Cash after chg. in Working capital 332.78 170.24 153.62 522.03 587.95 340.86 126.08 84.40 17.70 -46.54 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -42.02 -47.10 -62.58 -142.25 -117.15 -67.69 -6.36 -1.06 0.00 -0.42 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -191.69 -119.19 -120.62 -317.25 -184.23 -63.04 -50.38 -22.78 -27.37 -4.79 Net Fixed Assets -252.93 -217.16 -141.23 -110.99 -84.04 -58.45 -47.45 199.24 -25.77 4.03 Net Investments -0.32 -17.80 -1.25 -1.17 0.01 0.00 0.04 -0.01 -0.04 -0.05 Others 61.56 115.77 21.86 -205.09 -100.20 -4.59 -2.97 -222.01 -1.56 -8.77 Cash from Financing Activity -92.50 -4.11 -1.64 -58.28 -271.89 -197.46 -70.36 -59.78 9.27 49.69 Net Cash Inflow / Outflow 6.57 -0.16 -31.22 4.25 14.68 12.67 -1.02 0.78 -0.40 -2.07 Opening Cash & Equivalents 0.96 1.12 32.34 28.09 13.41 0.74 1.76 0.98 1.38 15.06 Closing Cash & Equivalent 7.53 0.96 1.12 32.34 28.09 13.41 0.74 1.76 0.98 12.99

Description Mar 24 Mar 23 Mar 22
Cash From Operating Activity 290.08 122.27 93.05 PBT 181.65 188.65 224.85 Adjustment 60.12 44.41 33.12 Changes in Working Capital 90.33 -63.69 -102.34 Cash after chg. in Working capital 332.10 169.37 155.63 Interest Paid 0.00 0.00 0.00 Tax Paid -42.02 -47.10 -62.58 Other Direct Exp. Paid 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 Cash From Investing Activity -191.28 -120.00 -120.52 Net Fixed Assets -252.93 -217.16 Net Investments -0.32 -17.80 Others 61.97 114.96 Cash from Financing Activity -92.50 -4.11 -1.64 Net Cash Inflow / Outflow 6.30 -1.84 -29.11 Opening Cash & Equivalents 1.39 3.23 32.34 Closing Cash & Equivalent 7.69 1.39 3.23

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 54.89 256.61 236.80 214.69 141.36 81.74 38.38 33.57 32.94 42.22 ROA 6.23% 6.85% 8.78% 28.69% 30.66% 25.50% 3.34% 0.59% -5.43% -9.24% ROE 8.69% 9.66% 12.50% 43.06% 56.93% 69.54% 13.70% 2.50% -20.72% -34.14% ROCE 12.30% 13.64% 17.16% 54.20% 68.09% 55.53% 15.03% 11.57% 3.68% -2.78% Fixed Asset Turnover 1.91 2.52 3.03 3.09 3.45 3.48 2.30 1.51 1.06 0.73 Receivable days 83.56 80.26 64.35 53.14 45.43 37.39 47.21 47.21 33.98 35.12 Inventory Days 64.21 60.53 58.91 44.78 36.26 42.92 85.71 115.79 125.04 173.90 Payable days 102.34 85.35 75.31 69.37 41.74 37.73 62.92 46.31 3.40 9.79 Cash Conversion Cycle 45.42 55.45 47.95 28.55 39.95 42.57 69.99 116.69 155.61 199.24 Total Debt/Equity 0.02 0.05 0.03 0.00 0.07 0.61 1.96 2.37 2.44 1.99 Interest Cover 12.34 12.51 27.88 99.01 26.48 7.54 1.49 1.09 0.37 -0.28

Description Mar 24 Mar 23 Mar 22
Book Value (Rs.) 54.90 256.81 237.15 ROA 6.18% 6.80% 8.28% ROE 8.62% 9.60% 12.04% ROCE 12.24% 13.57% 16.25% Fixed Asset Turnover 1.91 2.52 2.87 Receivable days 83.56 80.26 78.51 Inventory Days 64.21 60.53 68.50 Payable days 102.34 85.35 95.12 Cash Conversion Cycle 45.42 55.45 51.89 Total Debt/Equity 0.02 0.05 0.03 Interest Cover 12.28 12.45 28.12

Top Investors:

vasudeva commercials limited

g consultants and fabricators private limited

Annual Reports:

News Update:

IOL Chemicals registers Acetic Anhydride with REACH
16th Jun 2025, 12:30 PM

This certification allows the company to export the product across all the countries in the European Union
Read More
IOL Chemicals secures approval for Ibuprofen from CDE in China
29th Apr 2025, 12:12 PM

This approval authorizes the company to export Ibuprofen to the Chinese markets
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback